Related Resources – UNICOM

Presentations | Videos

Year	Title	Description	Download
2020	Polypharmacy from a clinical perspective	UNICOM partner Prof. Dr. R. Vander Stichele, Clinical pharmacologist at Ghent University, Belgium/ Senior Research Coordinator at I~HD, explains Polypharmacy concepts from a clinical perspective in the Horizon 2020 project C3-Cloud Webinar on 28 August 2020	PDF File
2020	White Paper written by nine SDOs, including CDISC, CEN, DICOM, GS1, HL7, IHE, ISO, LOINC and SNOMED International forming the Joint Initiative Council.	Highlights from the JIC white paper include four standards-based initiatives that offer practical solutions to real-world problems. These initiatives include the International Patient Summary (IPS), the Identification of Medicinal Products (IDMP), COVID-19 and Genomics. The Joint Initiative Council’s SDOs work collaboratively to provide global, coordinated—not competitive—standards that address real-world healthcare issues.	PDF File
2020	Presentation of UNICOM at SNOMED virtual expo-October 2020 - by Robert Stegmee and Jane Millar	The presentation describes the global problems tackled by UNICOM focusing more specifically on the relationship between IDMP and related terminologies. It explores also the role of SNOMED CT in this and informs about the ressources available to engage with the project.	PDF File
2020	Initial Gap Analysis on Standards Development -Presentation at HL7 International Work Group Biomedical Research & Regulation (BR&R) September 2020	Those 4 slides briefly summarize the identified gaps in WP1 for the HL7 WG audience	PDF File
2020	Keynote lecture by Prof. K. A. Stroetmann "Global patient safety through semantic interoperability - the univocal identification of medicinal products	Presentation made at a virtual evnet organized by the Tallinn Health Care College (THCC), Estonia in October 2020 on the theme: "Public Health & Healthcare in the Move — Opportunities and Challenges in Research, Practice and Policy	PDF File
2020	Commentary written by some UNICOM participants published in the review Vaccine	Commentary published in the open source journal Vaccine on December 5 2020. The authors detail the actions needed to ensure we can track and trace the global use of COVID-19 vaccines.	PDF File
2021	EHTEL factsheet: Towards a European Data Space for Medicines	This factsheet explains why the concept of European Health Data Spaces is particularly relevant for medicinal products with a focus on pharmacovigilance. It also analyses what has already been done by Member States in this field, with Belgium as an example, and considers the necessary next steps.	PDF File
2021	Ensuring COVID-19 Vaccine Traceability - Article published in the volume 21 of the review healthmanagement.org by several UNICOM WP leaders.	After the article published in Vaccine highlighted the need for global monitoring of vaccine use, HealthManagement.org has asked the authors about the challenges of implementing such system in practice and possible measures to minimise the accompanying risks.	PDF File
2021	UNICOM curent status - Presentation for the International Pharmaceutical Regulators Programme (IPRP) on the 24th of February	This slides set presnet to a wide community of regulators on all continents the objectives, opportunities of exchange and expected results o UNICOM. It inists in particular on the standards gap analysis, the logical model and the Products Pilot List.	PDF File

OpenMedicine

OpenMedicine was a Horizon 2020 funded PHC, Grant agreement No.643796. UNICOM builds on the gaps recognized in OpenMedicine. Some relevant deliverables are listed below for reference as background material.

Year	Title	Description	Download
2016	D1.3 Initial openMedicine infostructure	This deliverable’s goal is to present a multi standards framework that underpins solutions to identified issues in epSOS: the EU crossborder health data exchange specifications and its pilot results. In particular the identification of medicinal products and the attention to factors related to multiple contexts are addressed creating an infostructure, based on a multi standards framework.	PDF File
2016	D2.3 Final identifying and descriptive attributes	This deliverable’s goal is to present the final list of identifying and descriptive attributes of medicinal products. It also gives implementation recommendations based on the materials developed in other openMedicine deliverables. D2.3 has provided relevant input to D3.2, which will extend the attribute lists to special products.	PDF File
2016	D3.2 Identification and description of special products	This report extends the solution towards supporting the identification and the description of such “special” products. Furthermore, it also presents the definition of alternative and complementary use cases where the unambiguous identification of such medicinal or/and pharmaceutical products is needed.	PDF File
2016	D4.1 Other descriptive needs, product administration and alternative treatments	This document presents clusters as a tool for grouping products with the same preselected attributes. It explores the concepts behind cluster formation and useful attributes which can help in a cross-border setting for such purpose.	PDF File
2016	D5.2 Meeting the substitution challenge: Member State regulations and core cross-border issues - results and recommendations	This report reviews the initial openMedicine definitions of substitution and selection of a medicinal product at the point of dispensation in a community/retail pharmacy. the revised analytical framework concerning substitution and selection issues.	PDF File
2016	D6.3 Recommendations and Implementation Roadmap	This document presents some of the conclusions of the openMedicine project. Two high level and ten action-oriented recommendations are formulated. All of them, except one, address issues related to the univocal identification of a medicine when dispensing in a cross-border context an electronic prescription or when displaying a Patient Summary abroad. One recommendation addresses the issue of "substitution" in the EU.	PDF File

The UNICOM Innovation Action has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No. 875299.